Caribou Biosciences to Participate in Three Upcoming Investor Conferences in March
BERKELEY, Calif.–(BUSINESS WIRE)–Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced today that Rachel Haurwitz, Ph.D., Caribou’s President and Chief Executive Officer, will present a company overview at upcoming investor conferences in March.
- Barclays Global Healthcare Conference on Tuesday, March 9, 2021 at 1:15 p.m. ET
- Spring Private Company Showcase hosted by Solebury Trout, Credit Suisse, and Cooley on Thursday, March 11, 2021 at 11:40 a.m. ET
A live and archived webcast of the presentations will be accessible via Caribou’s website at https://cariboubio.com/news/events for 30 days following the events.
Additionally, the company will participate in meetings…